Assembly Biosciences (ASMB) Interest & Investment Income (2010 - 2026)
Assembly Biosciences (ASMB) posted quarterly Interest & Investment Income of -$327000.0 for Q1 2026, down 678.57% year-over-year from $56518.5 in Q1 2025, and down 105.57% quarter-over-quarter from $5.9 million in Q4 2025.
Powered by 
Analysis
Assembly Biosciences (ASMB) Interest & Investment Income (2010 - 2026) Analysis & Trends
Assembly Biosciences' Interest & Investment Income history runs 17 years deep, the most recent figure standing at -$327000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 678.57% year-over-year to -$327000.0; the TTM figure through Mar 2026 stood at $5.7 million (down 20.68% YoY), while the FY2025 annual figure was $6.0 million, up 7.59% from the prior year.
- Interest & Investment Income for Q1 2026 stood at -$327000.0, down from $5.9 million in the prior quarter.
- The five-year high for Interest & Investment Income was $5.9 million in Q4 2025, with the low at -$327000.0 in Q1 2026.
- The 5-year median for Interest & Investment Income is $189000.0 (2025), against an average of $1.1 million.
- The sharpest annual moves came in 2023 and 2026: Interest & Investment Income soared 62900.0% in 2023, then tumbled 678.57% in 2026.
- Assembly Biosciences' Interest & Investment Income stood at $196000.0 in 2022, then soared by 1391.33% to $2.9 million in 2023, then surged by 93.23% to $5.6 million in 2024, then gained by 4.02% to $5.9 million in 2025, then tumbled by 105.57% to -$327000.0 in 2026.
- Business Quant data shows ASMB's Interest & Investment Income at -$327000.0 in Q1 2026, $5.9 million in Q4 2025, and $189000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.26 Bn | 131.41 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.83 Bn | 52.69 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 39.94 Bn | 34.84 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.19 Bn | 31.88 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Assembly Biosciences | 692.40 Mn | 372.04 Mn | - | 2.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.49 Mn |
| Mar 31, 2026 | 2.29 Mn |
| Dec 31, 2025 | 2.29 Mn |
| Sep 30, 2025 | 1.69 Mn |
| Jun 30, 2025 | 895,000.00 |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 1.12 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | 1.65 Mn |
| Dec 31, 2023 | 1.62 Mn |
| Sep 30, 2023 | 628,000.00 |
| Jun 30, 2023 | 592,000.00 |
| Mar 31, 2023 | 609,000.00 |
| Dec 31, 2022 | 1.60 Mn |
| Sep 30, 2022 | 256,000.00 |
| Jun 30, 2022 | 112,000.00 |
| Mar 31, 2022 | -489,000.00 |
| Dec 31, 2021 | 101,000.00 |
| Sep 30, 2021 | 72,000.00 |